Orbitrex Peptides

Premium

Finnrick has tested 24 samples from Orbitrex Peptides across 3 products.

orbitrexpeptide.is/Finnrick verified this link on 31 Oct 2025

Vendor-Supplied Policies

Sample Authentication Guidance

Authentic sample should be identified by verifying the lid/crimp color match the lid/crimp color of the image on the COA that is contained on the label QR code.

Finnrick Vendor Profile

Orbitrex Peptides

Tracking 3 products

24 total samples tested

Last test 28 Apr 2026

Take Action

Test My Sample

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Products

Product	Rating	Count	Avg	Min	Max	Oldest	Most Recent
		Tests
GHK-Cu	A Great	3	8.4	7.0	9.2	25 Oct 2025	23 Apr 2026
Tirzepatide	A Great	4	8.8	8.2	9.2	23 Nov 2025	29 Mar 2026
Retatrutide	B Good	14	8.4	5.9	10.0	7 Oct 2025	28 Apr 2026

Some samples were submitted by Orbitrex Peptides as part of the Launch with Finnrick vendor support program. Samples are otherwise either acquired by Finnrick directly, or submitted by the public.

Customer Reviews

These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.

5.0

Based on 9 overall satisfaction reports

Ease of Purchase

5.0(9)

Payment Methods

5.0(9)

Delivery Speed

4.9(9)

Packaging Quality

4.7(9)

Customer Service

5.0(6)

People who submitted test requests to Finnrick gave Orbitrex Peptides an average satisfaction rating of 5.0 out of 5 across 9 reports associated with samples received and tested by Finnrick.

Most recent Orbitrex Peptides tests

Samples are tested in commercial labs

tests

products

Scores

AVG8.5MIN5.9MAX10.0

First

7 Oct 2025

Last

28 Apr 2026

				Quantity
Test Date	Product	Certificate	Test Score	Label	Batch	Tested	Difference	Purity	Endotoxins	Batch ID	Container	Tested At	Sent By
28 Apr 2026	Retatrutide	View	6.8	10mg	11.3mg	9.74mg	-13.7%	99.90%	n/a	3G101125	Black Label / Silver Crimp / Clear Blue Cap	Lab E	Public
28 Apr 2026	Retatrutide	View	5.9	36mg	49.0mg	36.9mg	-24.7%	99.90%	n/a	3G361125	Black Label / Gold Crimp / Clear Cap	Lab E	Public
23 Apr 2026	GHK-Cu	View	7.0	50mg	50.4mg	56.5mg	+12.2%	99.90%	below LOQ	GHK50326	Black Label / Silver Crimp / White Cap	Lab E	Public
23 Apr 2026	Retatrutide	View	10.0	10mg	(no batch claim)	9.88mg	-1.2%	99.90%	low	3G101125	Black Label / Silver Crimp / Clear Blue Cap	Lab E	Public
29 Mar 2026	Tirzepatide	View	8.8	10mg	11.4mg	11.6mg	+2.1%	99.80%	n/a	2G101125	Yellow Label / Silver Crimp / Yellow Cap	Lab G	Public
25 Mar 2026	Retatrutide	View	9.8	10mg	(no batch claim)	10.5mg	+5.0%	99.80%	n/a	3G101125	Black Label / Silver Crimp / Clear Blue Cap	Lab G	Public
18 Mar 2026	Retatrutide	View	6.9	10mg	11.3mg	9.83mg	-12.8%	99.90%	n/a	3G101125	(no data)	Lab E	Public

Corrections

9 Mar 2026: Retatrutide: Sample p4bqre8: original COA reported purity of 97.83%. Upon vendor objection, lab investigated and found the automated integration routine picked up noise as peaks and erroneously integrated it. Manual revision led to updated calculations for purity and quantity. The lab issued an updated COA. This sample's test score changed from 3.7 to 7.0, and the Finnrick Rating for Orbitrex Retatrutide changed from D to A.
9 Mar 2026: Tirzepatide: Sample nwwrwhu: original COA reported purity of 92.83%. Upon vendor objection, lab investigated and found the automated integration routine picked up noise as peaks and erroneously integrated it. Manual revision led to updated calculations for purity and quantity. The lab issued an updated COA. This sample's test score changed from 5.9 to 9.0, and the Finnrick Rating for Orbitrex Tirzepatide changed from B to A.